The diagnostic evaluation for GRS involves documentation of biochemical hypercortisolism with elevated or inappropriately normal ACTH levels, reflecting central resistance to glucocorticoid signaling, testing for mineralocorticoid and androgen excess, and genetic sequencing of the NR3C1 gene. Here, NR3C1 is linked to adrenal gland hyperfunction.